Trade

with

Enzon Pharmaceuticals Inc
(NASDAQ: ENZN)
AdChoices
0.9691
-0.0109
-1.11%
After Hours :
-
-
-

Open

0.9999

Previous Close

0.9800

Volume (Avg)

120.30k (539.53k)

Day's Range

0.9500-1.00

52Wk Range

0.7800-1.83

Market Cap.

43.24M

Dividend Rate ( Yield )

-

Beta

1.24

Shares Outstanding

44.13M

P/E Ratio (EPS)

1.63 (0.60)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 34.49M

    • Net Income

    • 18.15M

    • Market Cap.

    • 43.24M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 80.15

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.24

    • Forward P/E

    • -

    • Price/Sales

    • 1.31

    • Price/Book Value

    • 2.10

    • Price/Cash flow

    • 1.66

      • EBITDA

      • 20.48M

      • Return on Capital %

      • 137.19

      • Return on Equity %

      • 152.47

      • Return on Assets %

      • 137.19

      • Book Value/Share

      • 0.47

      • Shares Outstanding

      • 44.13M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -3.60

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • 45.80

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -29.42

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 100.00

            • 82.75

            • Pre-Tax Margin

            • 79.58

            • 39.38

            • Net Profit Margin

            • 80.15

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 94.80

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -2.10

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • 36.90

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 27.51

              • 2.92

              • Quick Ratio

              • 26.98

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 1.06

              • 2.21

              • Book Value/Share

              • 0.47

              • 4.76

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 1.61

                • 238.10

                • P/E Ratio 5-Year High

                • 21.18

                • 634.30

                • P/E Ratio 5-Year Low

                • 1.30

                • 124.82

                • Price/Sales Ratio

                • 1.29

                • 8.94

                • Price/Book Value

                • 2.06

                • 8.12

                • Price/Cash Flow Ratio

                • 1.66

                • 47.85

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 152.47

                        (25.50)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • 137.19

                        (11.00)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • 152.47

                        (13.40)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • 26.44M

                      • 117.08k

                      • Inventory Turnover

                      • -

                      • 1.48

                      • Asset Turnover

                      • 1.71

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      18.16M
                      Operating Margin
                      52.65
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      1.66
                      Ownership

                      Institutional Ownership

                      63.64%

                      Top 10 Institutions

                      45.50%

                      Mutual Fund Ownership

                      11.11%

                      Float

                      74.84%

                      5% / Insider Ownership

                      5.53%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • BlackRock Small Cap Growth Equity Port

                      •  

                        631,173

                      • 0.00

                      • 1.43

                      • Vanguard Extended Market Index Fund

                      •  

                        568,990

                      • 0.51

                      • 1.29

                      • Vanguard Total Stock Mkt Idx

                      •  

                        538,301

                      • 0.00

                      • 1.22

                      • Brandes Global Small Cap Equity Fund

                      •  

                        390,390

                      • 0.00

                      • 0.89

                      • DFA U.S. Micro Cap Portfolio

                      •  

                        301,457

                      • 0.00

                      • 0.68

                      • PowerShares FTSE RAFI US 1500 Sm-Md Port

                      •  

                        295,884

                      • 0.00

                      • 0.60

                      • Nationwide Bailard Cognitive Value Fund

                      •  

                        281,121

                      • -15.72

                      • 0.64

                      • DFA U.S. Small Cap Portfolio

                      •  

                        213,649

                      • 0.00

                      • 0.48

                      • Goldman Sachs Global Small Cap Core

                      •  

                        188,922

                      • 0.00

                      • 0.43

                      • BlackRock Master Small Cap Growth Port

                      •  

                        153,792

                      • 0.00

                      • 0.35

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Icahn Associates Corp

                      •  

                        5,904,863

                      • 0.00%

                      • 13.38

                      • BlackRock Fund Advisors

                      •  

                        3,138,340

                      • -9.44%

                      • 7.11

                      • Vanguard Group, Inc.

                      •  

                        1,247,815

                      • -3.60%

                      • 2.83

                      • Dimensional Fund Advisors, Inc.

                      •  

                        1,149,255

                      • -5.70%

                      • 2.60

                      • Renaissance Technologies Corp

                      •  

                        1,118,184

                      • +15.04%

                      • 2.53

                      • Brandes Investment Partners & Co.

                      •  

                        1,043,363

                      • -0.48%

                      • 2.36

                      • BlackRock Advisors LLC

                      •  

                        818,410

                      • -2.62%

                      • 1.85

                      • Price Michael F

                      •  

                        748,200

                      • 0.00%

                      • 1.70

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Slow Growth

                      Style

                      Small Value

                      Enzon Pharmaceuticals Inc is a biotechnology company. The Company is related to sales of six marketed drug products namely, PegIntron, Sylatron, Macugen, CIMZIA, Oncaspar and Adagen. The Company generates revenues from the royalty from the sales of PegIntron marketed by Merck & Co., Inc. The Company has a strategic alliance with Zhejiang Hisun Pharmaceuticals Co. Ltd development and commercialization rights for PEG-SN38 in China.

                      Key People

                      Mr. George W. Hebard, III

                      CEO/COO/Secretary

                      Mr. Jonathan Christodoro

                      Director/Chairman of the Board

                      Mr. Richard L. Feinstein

                      CFO/Chief Accounting Officer/Vice President, Divisional

                      Dr. Odysseas D. Kostas

                      Director

                      Ms. Jennifer McNealey

                      Director

                      • Enzon Pharmaceuticals Inc

                      • 20 Kingsbridge Road

                      • Piscataway, NJ 08854

                      • USA.Map

                      • Phone: +1 732 980-4500

                      • Fax: +1 908 575-9457

                      • enzon.com

                      Incorporated

                      0

                      Employees

                      1

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: